We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVZ icon
2726
Invesco
IVZ
$14.3B
$74K ﹤0.01%
+6,860
New +$61.5K
MGY icon
2727
Magnolia Oil & Gas
MGY
$6.13B
$74K ﹤0.01%
+12,184
New +$66.5K
MNKD icon
2728
MannKind Corp
MNKD
$1.2B
$74K ﹤0.01%
42,426
+37,770
+811% +$52.8K
PLAY icon
2729
Dave & Buster's
PLAY
$370M
$74K ﹤0.01%
5,503
+4,519
+459% +$60.2K
SITC icon
2730
SITE Centers
SITC
$158M
$74K ﹤0.01%
11,715
-12,870
-52% -$63K
URGN icon
2731
UroGen Pharma
URGN
$2.34B
$74K ﹤0.01%
+2,833
New +$69.2K
WPP icon
2732
WPP
WPP
$5.82B
$74K ﹤0.01%
1,901
+1,767
+1,319% +$65.7K
XES icon
2733
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$389M
$74K ﹤0.01%
2,245
-36,048
-94% -$1.09M
OFED
2734
DELISTED
Oconee Federal Financial Corp.
OFED
$74K ﹤0.01%
+2,887
New +$63.3K
SRRA
2735
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$74K ﹤0.01%
6,134
+5,816
+1,829% +$72.2K
AMC icon
2736
AMC Entertainment Holdings
AMC
$2.35B
$73K ﹤0.01%
+1,703
New +$74.5K
ANF icon
2737
Abercrombie & Fitch
ANF
$4.84B
$73K ﹤0.01%
+6,841
New +$74.7K
ANGO icon
2738
AngioDynamics
ANGO
$647M
$73K ﹤0.01%
+7,134
New +$73.5K
BEAM icon
2739
Beam Therapeutics
BEAM
$2.74B
$73K ﹤0.01%
+2,614
New +$56.3K
CMTL icon
2740
Comtech Telecommunications
CMTL
$52.7M
$73K ﹤0.01%
+4,292
New +$72.5K
CPS icon
2741
Cooper-Standard Automotive
CPS
$484M
$73K ﹤0.01%
5,549
+4,161
+300% +$50.5K
NBR icon
2742
Nabors Industries
NBR
$1.35B
$73K ﹤0.01%
+1,965
New +$56.5K
OSW icon
2743
OneSpaWorld
OSW
$2.73B
$73K ﹤0.01%
15,176
-1,819
-11% -$9.87K
TFIN icon
2744
Triumph Financial Inc
TFIN
$1.87B
$73K ﹤0.01%
2,995
+2,597
+653% +$63.7K
WLDN icon
2745
Willdan Group
WLDN
$1.29B
$73K ﹤0.01%
2,930
+2,057
+236% +$47.3K
AMTB icon
2746
Amerant Bancorp
AMTB
$1.14B
$72K ﹤0.01%
+4,751
New +$64.1K
BANC icon
2747
Banc of California
BANC
$3.11B
$72K ﹤0.01%
6,674
+2,293
+52% +$23K
CAC icon
2748
Camden National
CAC
$996M
$72K ﹤0.01%
+2,077
New +$65.7K
IXUS icon
2749
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
$72K ﹤0.01%
1,314
+1,245
+1,804% +$64K
JBSS icon
2750
John B. Sanfilippo & Son
JBSS
$1.01B
$72K ﹤0.01%
+847
New +$71.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.